InvestorsObserver
Sign Up Login

HQL Abrdn Life Sciences Investors Fu

$14.26 $0.00 (0.00%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

HQL Stock Analysis Overview

What this means: InvestorsObserver gives Abrdn Life Sciences Investors Fu (HQL) an overall rank of 30, which is below average. Abrdn Life Sciences Investors Fu is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 30 means that 70% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

HQL Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

HQL Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

HQL Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

HQL Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

HQL Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

HQL Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

HQL Stock Analysis Overview

What this means: InvestorsObserver gives Abrdn Life Sciences Investors Fu (HQL) an overall rank of 30, which is below average. Abrdn Life Sciences Investors Fu is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 30 means that 70% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full HQL report

HQL Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

HQL Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

HQL Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

HQL Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

HQL Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

HQL Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Abrdn Life Sciences Investors Fu (HQL) Analyst Forecast

HQL Price, Volume, Earnings, and Dividend Date

  • Last Price $14.26
  • Previous Close $14.26
  • Change $0.00
  • Open $14.06
  • Volume 109,441
  • Avg. Volume (100-day) 109,335
  • Market Cap 366,191,609
  • Days Range 14.06 - 14.29
  • 52-week Range 11.34 - 14.37
  • Dividend Yield 13.67%
  • Ex. Dividend Date 05/22/24
  • P-E —
  • EPS —
  • Earnings Date —
  • Sector Financial Services
  • Industry Asset Management
  • Avg. Analyst Rec. Premium
  • Beta 0.582
  • PEG Ratio —

Abrdn Life Sciences Investors Fu (HQL) Company Description

Tekla Life Sciences Investors is a United States based closedend management investment company. Its investment objective is to seek longterm capital appreciation by investing primarily in the securities of life sciences companies.

Abrdn Life Sciences Investors Fu (HQL) Stock Chart

View Interactive HQL chart

My Watchlists

Top Stocks in Asset Management